New webinar on demand! A Baby-Stepwise Approach to AUC→ WATCH NOW →

ALL DRUG MODELS

Simplify therapeutic drug monitoring with clinically validated drug models.

We have a range of drug models across various therapeutic areas including infectious disease, transplant medicine, cardiovascular and coagulation management, oncology, pediatrics, and more.

Richiedi una dimostrazione di prova
Parla con un rappresentante
Scroll to discover our drug models

Supporting you in delivering high-quality evidence-based medicine.

Our team of bioinformaticians, scientists, and clinical pharmacists meticulously select the best clinically-validated PK/PD models for DoseMeRx.

With a rigorous validation process, our approach follows best-practice quality assurance, ISO standards, and regulatory guidelines for implementing Bayesian dosing including an independent review by our Clinical Advisory Board.

DoseMeRx Drug Models

Questions about our clinically validated drug models, or looking to expediate a model currently in development?

Contact Us

Drug Models Key

A Adult       P Pediatric       N Neonatal

Infectious Diseases

Evaluation ⓘAssessment of potential drug models for safety and efficacy through comprehensive analyses to determine their viability for further development.
In Review ⓘModels undergoing a comprehensive review process at DoseMe.
Development ⓘModels being optimized for reliability and accuracy by DoseMe’s clinical experts.
Validation ⓘModels undergoing rigorous testing to ensure they meet scientific and clinical validity when implemented in DoseMeRx.
Market ⓘModels available immediately for dosing within DoseMeRx.
Amikacin  – AP
Bedaquiline – A
Cefepime – A
Ceftriaxone (PGx)
Daptomycin  – AP
Ethambutol – AP
Flucloxacillin – AN
Fluconazole 
Gentamicin – APN
Isavuconazole
Isoniazid – AP
Itraconazole – A
Itraconazole – P
Levofloxacin – A
Linezolid – A
Meropenem – A
Moxifloxacin – A
Para-aminosalicylic acid – A
Piperacillin – A
Posaconazole (IV) – A
Posaconazole (Tablet) – A
Pyrazinamide – AP
Rifampin 
Teicoplanin – A
Tobramycin  – APN
Vancomycin – APN
Vancomycin (hemodialysis) – A
Vancomycin (obese) – A
Voriconazole IV (PGx)
Voriconazole Oral (PGx) – A

Cardiovascular & Coagulation Management

Evaluation ⓘAssessment of potential drug models for safety and efficacy through comprehensive analyses to determine their viability for further development.
In Review ⓘModels undergoing a comprehensive review process at DoseMe.
Development ⓘModels being optimized for reliability and accuracy by DoseMe’s clinical experts.
Validation ⓘModels undergoing rigorous testing to ensure they meet scientific and clinical validity when implemented in DoseMeRx.
Market ⓘModels available immediately for dosing within DoseMeRx.
Dabigatran – A
Digoxin – A
Enoxaparin – A
Factor VIII – AP
Heparin
Warfarin Oral (PGx) – AP

Oncology

Evaluation ⓘAssessment of potential drug models for safety and efficacy through comprehensive analyses to determine their viability for further development.
In Review ⓘModels undergoing a comprehensive review process at DoseMe.
Development ⓘModels being optimized for reliability and accuracy by DoseMe’s clinical experts.
Validation ⓘModels undergoing rigorous testing to ensure they meet scientific and clinical validity when implemented in DoseMeRx.
Market ⓘModels available immediately for dosing within DoseMeRx.
Asparaginase
Busulfan – AP
Busulfan Oral – AP
Carboplatin – A
Cyclosporine Oral
Docetaxel
Fludarabine – AP
Imatinib Mesylate Oral – A
Methotrexate – AP
Methotrexate – Special Cohort
Velcade (Bortezomib) – A

Transplant Medicine

Evaluation ⓘAssessment of potential drug models for safety and efficacy through comprehensive analyses to determine their viability for further development.
In Review ⓘModels undergoing a comprehensive review process at DoseMe.
Development ⓘModels being optimized for reliability and accuracy by DoseMe’s clinical experts.
Validation ⓘModels undergoing rigorous testing to ensure they meet scientific and clinical validity when implemented in DoseMeRx.
Market ⓘModels available immediately for dosing within DoseMeRx.
Anti-thymocyte Globulin (ATG) – AP
Busulfan – AP
Busulfan Oral – AP
Cyclosporine Oral – A
Everolimus – A
Mycophenolate Mofetil – P
Sirolimus – AP
Tacrolimus (Prograf) Oral – A
Tacrolimus XL Oral A

Anticonvulsants

Evaluation ⓘAssessment of potential drug models for safety and efficacy through comprehensive analyses to determine their viability for further development.
In Review ⓘModels undergoing a comprehensive review process at DoseMe.
Development ⓘModels being optimized for reliability and accuracy by DoseMe’s clinical experts.
Validation ⓘModels undergoing rigorous testing to ensure they meet scientific and clinical validity when implemented in DoseMeRx.
Market ⓘModels available immediately for dosing within DoseMeRx.
Fosphenytoin
Phenytoin
Valproic Acid

Biologics

Evaluation ⓘAssessment of potential drug models for safety and efficacy through comprehensive analyses to determine their viability for further development.
In Review ⓘModels undergoing a comprehensive review process at DoseMe.
Development ⓘModels being optimized for reliability and accuracy by DoseMe’s clinical experts.
Validation ⓘModels undergoing rigorous testing to ensure they meet scientific and clinical validity when implemented in DoseMeRx.
Market ⓘModels available immediately for dosing within DoseMeRx.
Adalimumab (Humira)
Certolizumab (Cimzia)
Golimumab (Simponi)
Infliximab  – AP
Ustekinumab
Vedolizumab (Entyvio)

All drug models

Evaluation ⓘAssessment of potential drug models for safety and efficacy through comprehensive analyses to determine their viability for further development.
In Review ⓘModels undergoing a comprehensive review process at DoseMe.
Development ⓘModels being optimized for reliability and accuracy by DoseMe’s clinical experts.
Validation ⓘModels undergoing rigorous testing to ensure they meet scientific and clinical validity when implemented in DoseMeRx.
Market ⓘModels available immediately for dosing within DoseMeRx.
Adalimumab (Humira)
Amikacin  – AP
Anti-thymocyte Globulin (ATG) – AP
Asparaginase
Bedaquiline – A
Busulfan – AP
Busulfan Oral – AP
Carboplatin – A
Cefepime – A
Ceftriaxone (PGx)
Certolizumab (Cimzia)
Cyclosporine Oral – A
Dabigatran – A
Daptomycin  – AP
Digoxin – A
Docetaxel
Enoxaparin – A
Ethambutol – AP
Everolimus – A
Factor VIII – AP
Flucloxacillin – AN
Fluconazole 
Fludarabine – AP
Fosphenytoin
Gentamicin – APN
Golimumab (Simponi)
Heparin
Imatinib Mesylate Oral – A
Infliximab  – AP
Isavuconazole
Isoniazid – AP
Itraconazole – A
Itraconazole – P
Levofloxacin – A
Linezolid – A
Meropenem – A
Methotrexate – AP
Methotrexate – Special Cohort
Moxifloxacin – A
Mycophenolate Mofetil – P
Para-aminosalicylic acid – A
Phenytoin
Piperacillin – A
Posaconazole (IV) – A
Posaconazole (Tablet) – A
Pyrazinamide – AP
Rifampin 
Sirolimus – AP
Tacrolimus (Prograf) Oral – A
Tacrolimus XL Oral A
Teicoplanin – A
Tobramycin  – APN
Ustekinumab
Valproic Acid
Vancomycin – APN
Vancomycin (hemodialysis) – A
Vancomycin (obese) – A
Vedolizumab (Entyvio)
Velcade (Bortezomib) – A
Voriconazole IV (PGx)
Voriconazole Oral (PGx) – A
Warfarin Oral (PGx) – AP

Why should you choose DoseMeRx?

trusted by clincians
1:1 customer support

Spend more time on patients, less on calculations.

We combine smart technology with science leveraging clinically-validated PK/PD models, patient characteristics, drug concentrations, and genotype to accurately individualize a dose in seconds.

Explore features

Richiedi una dimostrazione di prova

Scopri quanto è facile usare e integrare DoseMeRx nel tuo lavoro quotidiano.

Richiedi una dimostrazione di prova qui sotto. Puoi anche chiamarci al numero +1 (832) 358-3308 oppure scriverci all’indirizzo hello@dosemehealth.com

HIPAA Privacy Statement | Privacy policy | DoseMe & the GDPR | Copyright © 2012 - 2024 DoseMe Pty Ltd. All Rights Reserved.
DoseMe® is a registered trademark of DoseMe Pty Ltd. DoseMeRx℠ and DoseMe℞℠ are service marks of DoseMe LLC.